HOME >> BIOLOGY >> NEWS
Progress toward a targeted therapy for a specific form of leukemia

Leuven, Belgium -- Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL. Now, VIB researchers connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10% of the T-ALL cases: MYB. The scientists have discovered that patients in this group have a duplication of the MYB gene, which increases MYB concentrations. Further research has indicated that MYB might well be an important target for therapies for this group of T-ALL patients.

T-cell acute lymphoblastic leukemia (T-ALL)

Our bodies white blood cells combat foreign intruders such as viruses and bacteria. However, in leukemia, the formation of white blood cells is disrupted. The cells in the bone marrow that should develop into white blood cells multiply out of control without fully maturing. These blood cells do not function properly and thus jeopardize the production of normal blood cells. Among other consequences, this makes patients more susceptible to infections. T-ALL is a certain form of leukemia in which immature T-cells (a specific type of blood cells) build up very rapidly. T-ALL is the most prevalent form of cancer in children under 14 years of age, striking children between the ages of 2 and 3 in particular. Today, with optimal treatment using chemotherapy, more than half of the children are cured.

Combined action of several players

The search for the mechanisms that cause T-ALL goes on ceaselessly. Discovering these mechanisms will enable the development of targeted therapies, which are preferred over chemotherapy. Scientists know that T-ALL arises only when defects occur in several genes simultaneously. So it is not only important to identify the genes that underlie T-ALL, but also to discover which combinations trigger the disease. This is an important step in
'"/>

Contact: Ann Van Gysel
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
15-Apr-2007


Page: 1 2 3

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress against sarcoma
3. Progress toward artificial photosynthesis?
4. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
5. Progress in battle against life-threatening acute allergy
6. Progress report on Homogeneous Assay project
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... (PRWEB) , ... February 05, 2019 , ... ... technologies, today announced it has partnered with MindFuel, a leading organization in educational ... in K-12 education. Amino Labs has pioneered a syn-bio starter kit ...
(Date:1/30/2019)... NEW YORK (PRWEB) , ... ... ... a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science ... investment professionals representing 10 national nonprofit disease foundations and disease-focused venture funds ...
(Date:1/21/2019)... ... January 20, 2019 , ... Energetiq Technology, a world leader in high ... the SPIE BIOS and SPIE Photonics West events taking place in San Francisco on ... #8526 at Bios and in booth #941 at Photonics West. There will be live ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... , ... K&R Negotiations announced today that Mladen Kresic, CEO and founder of ... Six Ways to Shorten the Sales Cycle : Reduce Complexity and Increase Win Rates, ... , Negotiation expert Kresic will discuss the realities of today’s complex selling environment ...
(Date:1/30/2019)... ... January 30, 2019 , ... In ... tasting 5StarWines to promote and give recognition to producers whose work focuses entirely ... selection takes place in Verona, Italy, contemporaneously to the 5StarWines blind tasting organized ...
(Date:1/24/2019)... ... January 22, 2019 , ... Outsourcing trials to contract ... of assumptions, and RFP creation and management generally requires manual effort. Additionally, each ... to oranges. These challenges can ultimately lead to study start delays and change ...
(Date:1/20/2019)... , ... January 17, 2019 , ... ... was, until recently, the exclusive purview of physicians. That's changing as many services ... direct to consumer (DTC) laboratory testing market totaled $208 million in 2018, according ...
Breaking Biology Technology:
Cached News: